TY - JOUR T1 - PC-SPES: A Potent Inhibitor of Nuclear Factor-κB Rescues Mice from Lipopolysaccharide-Induced Septic Shock JF - Molecular Pharmacology JO - Mol Pharmacol SP - 1521 LP - 1529 DO - 10.1124/mol.64.6.1521 VL - 64 IS - 6 AU - Takayuki Ikezoe AU - Yang Yang AU - David Heber AU - Hirokuni Taguchi AU - H. Phillip Koeffler Y1 - 2003/12/01 UR - http://molpharm.aspetjournals.org/content/64/6/1521.abstract N2 - Septic shock is the most common cause of death in intensive care units, and no effective treatment is available at present. Lipopolysaccharide (LPS) is the primary mediator of Gram-negative sepsis by inducing the production of macrophage-derived proinflammatory cytokines, in which activation of nuclear factor-κB (NF-κB) plays an important role. PC-SPES is an eight-herb mixture active against a variety of malignancies, including prostate cancer and leukemia. In this study, we demonstrated that PC-SPES inhibited the LPS-induced NF-κB reporter activity in RAW264.7 macrophages. Electrophoretic mobility shift assay showed that PC-SPES inhibited the binding of NF-κB to specific DNA sequences; however, it did not affect either degradation of inhibitory κBα or nuclear translocation of NF-κB. Also, we explored the effect of PCSPES on LPS-induced mitogen-activated protein (MAP) kinase signaling; PC-SPES did not affect LPS-induced phosphorylation of MAP kinases, including c-Jun NH2-terminal kinase, p38, and extracellular signal-regulated kinase 1/2. Moreover, PC-SPES decreased the production of proinflammatory cytokines and inducible enzymes, such as tumor necrosis factor (TNF) α, interleukin (IL)-1β, IL-6, cyclooxygenase-2, as well as inducible nitric-oxide synthase in RAW264.7 macrophages and peritoneal macrophages from C57BL/6 mice after the cells were stimulated by either LPS or LPS and interferon-γ. Furthermore, PC-SPES rescued C57BL/6 mice from death caused by LPS-induced septic shock in conjunction with decreased serum levels of TNFα and IL-1β. Together, PC-SPES is a potent inhibitor of NF-κB and might be useful for the treatment of sepsis and inflammatory diseases. ER -